
We have biotechnology platforms and experience in developing various types of high-quality antibodies, such as structure-specific antibodies, antibodies that distinguish microstructural differences, and neutralizing antibodies used for biopharmaceutical analysis.
We have various immunoassay development technologies that have high sensitivity and precision, and we are developing various products using these technologies.
In addition, we possess nanoparticle-related technologies such as gold nanoparticle optimization technology and fluorescent particle manufacturing technology, and they are used as labels for in vitro diagnostic products to achieve high sensitivity and perform more accurate quantitative analysis.

Structure-specific antibody development technology
Single injection recognition antibody development technology
Neutralizing antibody development technology
Antibody characterization and screening technology

Bioreactor-based mass production to produce antibody-based pharmaceuticals
Ensuring the homogeneity of the raw materials of antibodies

Development of immunochromatography using gold nanoparticles
(coronavirus disease 2019 (COVID-19)-related rapid antigen diagnosis, COVID-19-related rapid antigen and antibody diagnosis, pregnancy/ovulation/menopause hormone test, etc.)

Technology to quantitatively analyze antigen-antibody reactions using fluorescent labels (C-reactive protein (CRP), Total IgE, hemoglobin A1c, etc.)
High-sensitivity testing possible through time-resolved fluorescence (TRF) technology using Europium particles (Troponin I, PCT , COVID-19-related antigen test, etc.)

Immunoassay technology that can test dozens of biomarkers in one strip
(Allergy-specific antibody test, autoimmune antibody test, etc.)

Immunoassay technology for analysis using 96-well plates and enzyme conjugates
(COVID-19-related antibody test, COVID-19-related neutralizing antibody test, etc.)

Nanoparticle production technology of uniform size
Gold Nanoparticle Analysis Technology to ensure Reproducibility
Ensuring high sensitivity with antibody-gold nanoparticle conjugation technology

Unique fluorescent microsphere production technology(patented)
Production of fluorescent nanoparticles of uniform size
Implementation of high sensitivity reporting and photobleaching stability

High-efficiency conjugation technology by diagnostic markers
Technology to maximize the signal to noise ratio for high-sensitivity detection